Senate panel release of text chain says Anthony Fauci discussed potential COVID mRNA fever risk in early pregnancy

A text-message chain released by a Senate committee includes discussion attributed to Dr. Anthony Fauci about concerns involving COVID-19 mRNA vaccination for pregnant women, according to a Fox News report on Aug. 10, 2026. The messages describe a theoretical risk scenario in which fever following a second mRNA vaccine dose could occur during the first trimester, potentially raising miscarriage concerns, Fox reported.

Fox News said the committee released the texts as part of its oversight of COVID-era public health messaging and guidance, focusing on how officials communicated potential adverse effects and the limits of what clinicians could know at the time. The report characterizes the discussion as centered on the physiological effects of fever in early pregnancy, rather than a claim that miscarriage is caused directly by vaccination.

In the account described by Fox News, the exchange ties the pregnancy timeline to the timing of an mRNA dose, with the issue framed around first-trimester exposure and the possibility of fever after the second dose. The report does not establish that fever-related miscarriage occurred, and it instead presents the point as a theoretical or clinical concern that was raised in communications among health officials.

The disclosure comes amid continued scrutiny on how federal health officials discussed vaccine safety during pregnancy and how that information was conveyed to the public. Oversight inquiries have repeatedly examined the chain of communication between federal scientists and government health structures, as well as the degree to which uncertainty was communicated when evidence was still emerging.

The practical stakes for pregnant patients and clinicians are the need for clear risk communication and consistent guidance on what health professionals should monitor after vaccination, including what symptoms might require medical attention. For policymakers, the record of how officials discussed conditional risks can inform questions about federal accountability, including what was said, when, and to whom, as well as how those communications translated into official messaging.

The committee release also underscores the continuing congressional role in reviewing executive-branch public health guidance. Depending on the committee’s broader inquiry goals, the texts may be used to test whether officials’ internal discussions matched later public statements, and whether uncertainty around pregnancy-related outcomes was handled with sufficient specificity.

Next steps will depend on the Senate committee’s follow-on actions, including whether it expands its request for records, calls additional witnesses, or uses the material in further legislative or oversight hearings. As of the report, the text chain remains central to the question of how vaccine safety concerns relating to pregnancy and fever were discussed internally by senior health figures.